#Rituximab is an anti-CD20 monoclonal antibody medication used to treat some oncology diseases (B-cell non-Hodgkin's lymphoma, B-cell chronic lymphocytic leukemia etc) and autoimmune disorders. It targets and helps the immune system destroy B-cells, which are a type of white blood cells. Rituximab is approved for several non-cancer conditions, primarily severe autoimmune diseases, where B-cells play a key role in causing inflammation and tissue damage. In these disorders, ri